MedPath

Brain-Derived Neurotrophic Factor level in Depressive patients

Not Applicable
Conditions
Major Depressive Disorder.
Depressive episode
Registration Number
IRCT201312271743N12
Lead Sponsor
Research center for behavioral disorders and substance abuse, Hamadan university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Inclusive Criteria 1. Patients with unipolar major depressive disorder admitted in one of the psychiatric wards of Farshchian Hospital 2. Aged of 18-40 years 3. No systemic diseases such as diabetes, hypertension, epilepsy and etc 4. No history of alcohol abuse or other illegal substances 5. Patient’s informed consent Exclusive Criteria 1. Incidence of uncontrollable somatic condition 2. Patient’s unwillingness to continue participation

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of symptoms of Depression. Timepoint: Baseline and 4 weeks after treatment. Method of measurement: Hamiltone Depression scale.;Level of Brain-derived neurotrophic factor in serum. Timepoint: Baseline and 4 weeks after treatment. Method of measurement: ELISA.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath